|
Q |
Anxrr39 |
Anxiety related response QTL 39 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
|
|
Q |
Anxrr40 |
Anxiety related response QTL 40 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:64,084,079...109,084,079
|
|
Q |
Anxrr42 |
Anxiety related response QTL 42 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:146,370,897...184,426,481
|
|
Q |
Anxrr47 |
Anxiety related response QTL 47 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:11,038,706...56,038,706
|
|
Q |
Anxrr49 |
Anxiety related response QTL 49 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:64,084,079...109,084,079
|
|
Q |
Anxrr50 |
Anxiety related response QTL 50 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
|
|
Q |
Anxrr51 |
Anxiety related response QTL 51 |
|
IDA |
|
RGD |
PMID:21516450 |
RGD:6218999 |
NCBI chr 4:126,334,185...171,334,185
|
|
Q |
Emca1 |
Estrogen-induced mammary cancer QTL 1 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:104,262,817...153,890,625
|
|
Q |
Emca10 |
Estrogen-induced mammary cancer QTL 10 |
|
IDA |
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 6:22,288,257...27,729,050
|
|
Q |
Emca11 |
Estrogen-induced mammary cancer QTL 11 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:73,176,602...118,176,602
|
|
Q |
Emca12 |
Estrogen-induced mammary cancer QTL 12 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:94,034,903...139,034,903
|
|
Q |
Emca13 |
Estrogen-induced mammary cancer QTL 13 |
|
IDA |
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:14,606,078...59,606,078
|
|
Q |
Emca2 |
Estrogen-induced mammary cancer QTL 2 |
|
IDA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:65,846,447...86,134,022
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IDA |
27.5mg crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IDA |
27.5mg crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:145,335,553...189,428,310
|
|
Q |
Emca6 |
Estrogen-induced mammary cancer QTL 6 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:45,429,709...157,555,683
|
|
Q |
Emca7 |
Estrogen-induced mammary cancer QTL 7 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:20,859,430...113,082,285
|
|
Q |
Emca8 |
Estrogen-induced mammary cancer QTL 8 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:55,124,766...172,190,305
|
|
Q |
Ept15 |
Estrogen-induced pituitary tumorigenesis QTL 15 |
|
IDA |
|
RGD |
PMID:2292503 |
RGD:7175546 |
NCBI chr 6:1...44,788,383
|
|
Q |
Ept16 |
Estrogen-induced pituitary tumorigenesis QTL 16 |
|
IDA |
|
RGD |
PMID:2292503 |
RGD:7175546 |
NCBI chr 3:67,641,995...130,815,812
|
|
Q |
Ept17 |
Estrogen-induced pituitary tumorigenesis QTL 17 |
|
IDA |
|
RGD |
PMID:2292503 |
RGD:7175546 |
NCBI chr 3:6,556,347...51,556,347
|
|
Q |
Ept18 |
Estrogen-induced pituitary tumorigenesis QTL 18 |
|
IDA |
|
RGD |
PMID:2292503 |
RGD:7175546 |
NCBI chr10:73,950,353...96,620,293
|
|
Q |
Ept5 |
Estrogen-induced pituitary tumorigenesis QTL 5 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 4:100,752,691...179,366,077
|
|
Q |
Ept7 |
Estrogen-induced pituitary tumorigenesis QTL 7 |
|
IDA |
27.5mg/ml crystalline implant |
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q |
Eutr1 |
Estrogen induced uterine response QTL 1 |
|
IDA |
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:6,922,282...81,330,203
|
|
|
Q |
Rf16 |
Renal function QTL 16 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 6:1...40,163,351
|
|
Q |
Rf22 |
Renal function QTL 22 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr14:42,616,258...99,224,555
|
|
Q |
Rf32 |
Renal function QTL 32 |
|
IDA |
|
RGD |
PMID:11721057 |
RGD:70849 |
NCBI chr 5:134,369,199...172,190,305
|
|
Q |
Rf37 |
Renal function QTL 37 |
|
IDA |
|
RGD |
PMID:11721057 |
RGD:70849 |
NCBI chr 6:86,494,122...112,380,234
|
|
Q |
Rf41 |
Renal function QTL 41 |
|
IDA |
|
RGD |
PMID:11721057 |
RGD:70849 |
NCBI chr12:1...33,700,556
|
|
Q |
Rf42 |
Renal function QTL 42 |
|
IDA |
|
RGD |
PMID:11721057 |
RGD:70849 |
|
|
Q |
Rf45 |
Renal function QTL 45 |
|
IDA |
|
RGD |
PMID:11721057 |
RGD:70849 |
NCBI chr19:31,777,888...74,246,245
|
|
Q |
Rf8 |
Renal function QTL 8 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 1:237,995,023...269,633,915
|
|
|
Q |
Rends1 |
Renal damage susceptibility QTL 1 |
|
IDA |
|
RGD |
PMID:10454439 |
RGD:632218 |
NCBI chr 1:139,442,053...223,964,440
|
|
|
Q |
Edpm1 |
Estrogen-dependent pituitary mass QTL 1 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 2:36,868,643...81,868,643
|
|
Q |
Edpm10 |
Estrogen-dependent pituitary mass QTL 10 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
|
|
Q |
Edpm11 |
Estrogen-dependent pituitary mass QTL 11 |
|
IDA |
|
RGD |
PMID:11003699 |
RGD:629550 |
NCBI chr 9:6,214,995...51,214,995
|
|
Q |
Edpm12 |
Estrogen-dependent pituitary mass QTL 12 |
|
IDA |
|
RGD |
PMID:11003699 |
RGD:629550 |
|
|
Q |
Edpm2 |
Estrogen-dependent pituitary mass QTL 2 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 2:78,269,809...205,135,428
|
|
Q |
Edpm3 |
Estrogen-dependent pituitary mass QTL 3 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 3:73,592,611...110,333,156
|
|
Q |
Edpm5 |
Estrogen-dependent pituitary mass QTL 5 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
NCBI chr 5:73,779,642...103,472,210
|
|
Q |
Edpm9 |
Estrogen-dependent pituitary mass QTL 9 |
|
IDA |
|
RGD |
PMID:9337394 |
RGD:61074 |
|
|
Q |
Ept1 |
Estrogen-induced pituitary tumorigenesis QTL 1 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 6:1...44,788,383
|
|
Q |
Ept10 |
Estrogen-induced pituitary tumorigenesis QTL 10 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
|
|
Q |
Ept13 |
Estrogen-induced pituitary tumorigenesis QTL 13 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:86,622,262...131,622,262
|
|
Q |
Ept2 |
Estrogen-induced pituitary tumorigenesis QTL 2 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:67,641,995...130,815,812
|
|
Q |
Ept6 |
Estrogen-induced pituitary tumorigenesis QTL 6 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:6,556,347...51,556,347
|
|
Q |
Ept9 |
Estrogen-induced pituitary tumorigenesis QTL 9 |
|
IDA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr10:73,950,353...96,620,293
|
|
Q |
Esta1 |
Estrogen-induced thymic atrophy QTL 1 |
|
IDA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr10:21,833,758...61,843,633
|
|
Q |
Esta2 |
Estrogen-induced thymic atrophy QTL 2 |
|
IDA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:192,287,802...229,609,668
|
|
Q |
Esta3 |
Estrogen-induced thymic atrophy QTL 3 |
|
IDA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:139,067,258...192,287,892
|
|
Q |
Esta4 |
Estrogen-induced thymic atrophy QTL 4 |
|
IDA |
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 3:67,641,776...167,835,660
|
|
Q |
Eutr2 |
Estrogen induced uterine response QTL 2 |
|
IDA |
|
RGD |
PMID:16284802 |
RGD:1559291 |
NCBI chr 5:39,526,924...84,526,924
|
|
Q |
Teswt1 |
Testicular weight QTL 1 |
|
IDA |
|
RGD |
PMID:16651691 |
RGD:1625009 |
NCBI chr 7:82,111,245...96,700,643
|
|
Q |
Teswt2 |
Testicular weight QTL 2 |
|
IDA |
|
RGD |
PMID:16651691 |
RGD:1625009 |
NCBI chr 1:203,675,682...248,675,682
|
|
|
Q |
Gluco11 |
Glucose level QTL 11 |
|
IDA |
|
RGD |
PMID:15752738 |
RGD:1357415 |
NCBI chr 4:86,709,649...168,870,974
|
|
Q |
Gluco12 |
Glucose level QTL12 |
|
IDA |
|
RGD |
PMID:15752738 |
RGD:1357415 |
|
|
Q |
Gluco16 |
Glucose level QTL 16 |
|
IDA |
|
RGD |
PMID:9171835 |
RGD:61078 |
NCBI chr 4:1...31,106,810
|
|
Q |
Gluco17 |
Glucose level QTL 17 |
|
IDA |
|
RGD |
PMID:9171835 |
RGD:61078 |
NCBI chr12:1...16,966,671
|
|
Q |
Gluco3 |
Glucose level QTL 3 |
|
IDA |
|
RGD |
PMID:9171835 |
RGD:61078 |
NCBI chr12:1...16,966,671
|
|
Q |
Gluco4 |
Glucose level QTL 4 |
|
IDA |
|
RGD |
PMID:9171835 |
RGD:61078 |
NCBI chr 4:1...34,142,783
|
|
Q |
Gluco5 |
Glucose level QTL 5 |
|
IDA |
|
RGD |
PMID:9171835 |
RGD:61078 |
NCBI chr 4:1...34,142,783
|
|
|
Q |
Bp185 |
Blood pressure QTL 185 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 9:68,875,497...121,768,150
|
|
Q |
Bp191 |
Blood pressure QTL 191 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr15:1...15,177,511
|
|
Q |
Rf11 |
Renal function QTL 11 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 3:141,508,991...166,376,254
|
|
Q |
Rf12 |
Renal function QTL 12 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 3:81,425,008...141,509,147
|
|
Q |
Rf13 |
Renal function QTL 13 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 4:176,806,581...181,925,369
|
|
Q |
Rf14 |
Renal function QTL 14 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 6:40,163,183...85,163,183
|
|
Q |
Rf15 |
Renal function QTL 15 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
NCBI chr 6:3,239,989...48,239,989
|
|
Q |
Rf17 |
Renal function QTL 17 |
|
IDA |
|
RGD |
PMID:14532335 |
RGD:727992 |
|
|
Q |
Rf38 |
Renal function QTL 38 |
|
IDA |
|
RGD |
PMID:11721057 |
RGD:70849 |
NCBI chr 6:31,185,002...76,185,002
|
|
Q |
Rf40 |
Renal function QTL 40 |
|
IDA |
|
RGD |
PMID:11721057 |
RGD:70849 |
NCBI chr10:29,800,910...64,653,589
|
|